Create Alert
Watchlist

Glenmark Pharmaceuticals

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹54,302Cr
ROE14.89%
P/E Ratio(TTM)72.04
EPS(TTM)26.71
P/B Ratio6.14
Dividend Yield0.13%
Industry P/E34.34
Book Value313.59
Debt to Equity0.28
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Glenmark Pharma

Glenmark Pharmaceuticals Limited is an India-based global pharmaceutical company. The Company is focused on building a global formulation business with branded, generics and over the counter (OTC) segments in the therapy areas of dermatology, respiratory and oncology. The Company also has a regional/country-specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives. Its product portfolio includes topical products, liquids, respiratory MDI/DPI, complex injectables and biologics, and oral solids. The Company has a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand, Tiogiva in the United Kingdom and Tavulus in Spain, for the treatment of chronic obstructive pulmonary disease. Ryaltris, the Company's first branded specialty product globally, is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis.;
Parent OrganisationGlenmark Pharmaceuticals Limited
Managing DirectorMr. Glenn Saldanha
NSE SymbolGLENMARK

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
46.65%
Foreign Institutions
20.62%
Mutual Funds
15.55%
Retail And Others
15.09%
Other Domestic Institutions
2.09%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
36.87
Cipla
NA
(0.00%)
23.81
Dr Reddy's Laboratories
NA
(0.00%)
18.55
Mankind Pharma
NA
(0.00%)
53.89